# A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent

> **NCT00299026** · PHASE2 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 532 (—)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** NIRx(TM) Paclitaxel-Coated Conformer Coronary Stent System

## Key facts

- **NCT ID:** NCT00299026
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2003-05
- **Final completion:** 2007-02
- **Target enrollment:** 532 (—)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00299026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00299026, "A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT00299026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*